clinical trial · NCT03346538
Dose Finding Study of MCI-186 in Acute Ischemic Stroke
Acute Ischemic StrokeContinuous infusion high-dose MCI-186Continuous infusion low-dose MCI-186Continuous infusion placeboApproved dosing regimen MCI-186Approved dosing regimen placebo
brief summary
To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.
started
Nov 17, 2017
primary completion
May 14, 2018
completion
May 14, 2018
last updated
Jul 16, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol